Business Wire

Mary Kay Highlights the Importance of Women’s Leadership and Private Sector Engagement in Conservation at the World Ocean Summit 2023 Hosted by Economist Impact

22.3.2023 19:02:00 EET | Business Wire | Press release

Share

Mary Kay Inc., a global advocate for corporate sustainability and signatory to the UN Global Compact Sustainable Ocean Principles, continues to play an important role in ocean conservation. In February, the beauty brand launched a groundbreaking, user-friendly platform offering valuable guidance, decision-support tools, and practical knowledge for marine practitioners. Following the announcement, Mary Kay recently participated at the 10th World Ocean Summit and Expo 2023 in Lisbon, Portugal, organized by Economist Impact.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230322005544/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Sandra Silva, Mary Kay Portugal’s General Manager participates on a panel on the topic of "Putting Coral Reef Restoration at the Heart of Ocean Conservation Action" at the World Ocean Summit in Lisbon, Portugal (Credit: Mary Kay Inc.).

The World Ocean Summit is an annual global event that brings together the widest cross-section of the ocean community, from business and finance to governments, national and international policymakers, civil society, and academia. Over 1,500 attendees from more than 100 countries attended the three-day summit, where 188 speakers addressed some of the most pressing challenges facing the ocean, such as climate change, biodiversity loss, and pollution.

Mary Kay Portugal's General Manager, Sandra Silva, was one of the distinguished panelists at the summit's "Putting Coral Reef Restoration at the Heart of Ocean Conservation Action" discussion, where she joined other notable speakers including Yabanex Batista from the Global Fund for Coral Reefs (United Nations), Tom Moore from King Abdullah University of Science and Technology (Saudi Arabia), and Deborah Brosnan from Deborah Brosnan & Associates.

Silva emphasized the importance of ocean conservation, stating, "The ocean is critical for the livelihoods of billions of people, and we all have a role to play in ocean conservation and a sustainable ocean economy. Mary Kay supports women's empowerment in all facets of life and business, including the health of our planet."

Martin Koehring, head of Economist Impact's World Ocean Initiative, stated, "Keeping momentum on ocean action, including through our summit and publications, is vital. This year, the summit drove progress by featuring cross-industry sessions to leverage synergies and encourage cross-sector engagement. Mary Kay's participation in the World Ocean Summit and Expo 2023 demonstrates its continued commitment to ocean conservation and its dedication to creating a sustainable future for all.”

The World Ocean Initiative transforms the momentum and focal point of the World Ocean Summit into a year-round program on the ocean that powers the full capabilities of Economist Impact, combining the ingenuity of a think-tank with the creativity of a media brand to engage a globally influential audience. The World Ocean Initiative seeks to enlighten, motivate and cultivate better collaboration between businesses, policymakers, investors, scientists, and NGOs to seek solutions to the most pressing ocean challenges and opportunities.

Mary Kay has been working to elevate ocean health and coral reef awareness through its partnership with The Nature Conservancy for over 32 years. One of the key projects Mary Kay supports is called "Super Reefs," which identifies, protects, and grows a global network of highly resilient coral reefs that can survive in a warming ocean.

“The Super Reefs team brings together reef governments and communities with experts in ocean science, conservation, and management from Woods Hole Oceanographic Institution, Stanford University, and The Nature Conservancy, along with private sector support from Mary Kay at this critical moment in the history of coral reefs,” said Dr. Elizabeth McLeod with The Nature Conservancy.

Click here to watch Putting Coral Reef Restoration At The Heart Of Ocean Conservation Action panel discussion.

DID YOU KNOW?

  • The CEO Water Mandate is a UN Global Compact initiative that mobilizes business leaders on water, sanitation, and the United Nations Sustainable Development Goals. (Mary Kay is a signatory and joined in February 2021).
  • The Sustainable Ocean Principles, produced in consultation with over 300 stakeholders, provide a framework for responsible business practices across sectors and geographies. They build upon and supplement the Ten Principles of the United Nations Global Compact on human rights, labor, environment, and anti-corruption. (Mary Kay is a signatory and joined in February 2021).
  • The ocean has a key role to play in transitioning to a net-zero, resilient, and equitable economy, and delivering on the entire 2030 Agenda for Sustainable Development. The global business community has a shared responsibility, to take necessary action to secure a healthy ocean. (Mary Kay is a member and joined in August 2022).

ABOUT MARY KAY

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in more than 35 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

About The Nature Conservancy

The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters, and oceans at an unprecedented scale, providing food and water sustainably, and helping make cities more sustainable. Working in 76 countries and territories —37 by direct conservation impact and 39 through partners— we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.

About the World Ocean Initiative

Economist Impact's World Ocean Initiative supports the development of a sustainable ocean economy by addressing the greatest challenges facing our seas: climate change, biodiversity loss, and pollution. Year-round and at our flagship World Ocean Summit, we inspire bold thinking, enable new partnerships, and explore the most effective action for a healthy blue planet. Find out more at impact.economist.com/ocean.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye